ASX:ILAPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals
Island Pharmaceuticals Ltd
$0.365
+$0.015 (+4.29%)
Day Range
$0.360 – $0.370
52 Week Range
$0.130 – $0.630
Volume
158.87K
Avg Volume (10D)
210.74K
Market Cap
$108.01M
Price Chart
Market Statistics
Open$0.360
Previous Close$0.350
Day High$0.370
Day Low$0.360
52 Week High$0.630
52 Week Low$0.130
Valuation
Market Cap108.01M
Shares Outstanding295.92M
Price to Book13.91
Trading Activity
Volume158.87K
Value Traded57.84K
Bid$0.355 × 60,000
Ask$0.370 × 45,499
Performance
1 Day-2.63%
5 Day-2.63%
13 Week-11.90%
52 Week80.49%
YTD-13.95%
Technical Indicators
RSI (14)47.38
50-Day SMA$0.372
200-Day SMA$0.396
Latest News
Biotechnology
Island Pharmaceuticals Expands USAMRIID Agreement for Galidesivir Marburg Study
Island Pharmaceuticals expands USAMRIID CRADA to dose-optimise Galidesivir Marburg study; trials start next quarter; topline results H2 2026, a major milestone.
Biotechnology
Island Pharmaceuticals Strengthens Biodefence Engagement for Galidesivir Advancement
Island Pharmaceuticals strengthens US biodefence push with new adviser Mark Herzog, MC2 roles, and Galidesivir progress toward FDA Animal Rule trials.
Biotechnology
Island Pharma Expands Antiviral Pipeline with Burnet Institute Collaboration and NHMRC Funding
Island Pharma expands antiviral pipeline with Burnet Institute; NHMRC grant of over $780k to back ISLA-101, accelerating Galidesivir MVD program.
Biotechnology
Island Pharma Partners with USAMRIID and Geneva Foundation for Galidesivir under FDA Animal Rule
Island Pharma signs a 3-year CRADA with USAMRIID and Geneva Foundation to fast-track Galidesivir for Marburg under FDA Animal Rule, eyeing NDA.